The biotechnology startup Pandorum Technologies, situated in Bangalore, India, has raised $11 million in capital.
Mr. Ashish Kacholia, Acebright Pharma, Ms. Bandana Kankani’s syndicate, Mr. Sunil Kant Munjal, the Indian Angel Network, and other current investors supported the initiative.
The money will be used by the business to increase operations and R&D.
Pandorum Technology is a tissue engineering and regenerative medicine company founded by Arun Chandru and Dr. Tuhin Bhowmick.
The company uses basic and translational principles of biology and engineering to design therapeutic products that aim to improve the health conditions of patients suffering from liver diseases, lung related disorders, and corneal dystrophies.
With the help of cells, gels, and cell modulators, Pandorum can also create 3D functional tissues. Self-assembly, 3D printing, and other fabrication techniques can be used to create the desired tissue, such as micro-architecture.
With the help of its patented technology platform, functional human tissues can be created for therapeutic and medical purposes, such as bio-engineered liver and cornea.
“We are thrilled to have the support of the notable investors, including Mr. Ashish Kacholia- as we continue to innovate and develop therapeutics to restore healthy tissue functions, in order to help the patients suffering from unmet clinical needs. Kuragenx, our flagship product, guides the formation of a functional corneal tissue to restore vision by combining regenerative nanotherapy with proprietary biomaterials. The distinction between treatment and cure can actually be blurred with this best-in-class methodology.”
Tuhin Bhowmick
